Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

Completed · Phase 1 · Has a placebo group

Conditions studied: Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer

In brief

This randomized phase I trial studies the side effects and best dose of defined green tea catechin extract in treating women with hormone receptor-negative stage I-III breast cancer. Green tea extract contains ingredients that may prevent or slow the growth of breast cancer.

Key facts

Study ID

NCT00516243

Run by

National Cancer Institute (NCI)

People needed

40

Starts

2007-07-01

Expected to finish

2010-03-01

Last updated by the study team

2014-09-12

Who can join

Age: 21 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Columbia University Medical Center — New York, New York, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Baylor College of Medicine — Houston, Texas, United States
• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.